I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.1 SEK 2.9%
Market Cap: 375.7m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Initiator Pharma A/S
Net Income Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Net Income
-kr27.7m
CAGR 3-Years
-38%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Net Income
kr7.5B
CAGR 3-Years
35%
CAGR 5-Years
44%
CAGR 10-Years
50%
Zealand Pharma A/S
CSE:ZEAL
Net Income
-kr1.1B
CAGR 3-Years
2%
CAGR 5-Years
-16%
CAGR 10-Years
-37%
Ascendis Pharma A/S
NASDAQ:ASND
Net Income
-€489.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Net Income
kr707.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
88%
Bioporto A/S
CSE:BIOPOR
Net Income
-kr55.9m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
-11%

See Also

What is Initiator Pharma A/S's Net Income?
Net Income
-27.7m DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Net Income amounts to -27.7m DKK.

What is Initiator Pharma A/S's Net Income growth rate?
Net Income CAGR 5Y
-17%

Over the last year, the Net Income growth was 37%. The average annual Net Income growth rates for Initiator Pharma A/S have been -38% over the past three years , -17% over the past five years .

Back to Top